Published in Bioconjug Chem on June 20, 2008
Synthesis and properties of star-comb polymers and their doxorubicin conjugates. Bioconjug Chem (2011) 1.42
A novel size-tunable nanocarrier system for targeted anticancer drug delivery. J Control Release (2010) 1.42
Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles. Biomaterials (2013) 1.00
Synthesis and characterization of thermoresponsive polyamidoamine-polyethylene glycol-poly(D,L-lactide) core-shell nanoparticles. Acta Biomater (2009) 0.99
Evaluation of triblock copolymeric micelles of δ- valerolactone and poly (ethylene glycol) as a competent vector for doxorubicin delivery against cancer. J Nanobiotechnology (2011) 0.87
High drug-loading nanomedicines: progress, current status, and prospects. Int J Nanomedicine (2017) 0.75
Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst (2002) 1.77
The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett (1989) 1.25
Synthesis and evaluation of a star amphiphilic block copolymer from poly(epsilon-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier. Bioconjug Chem (2005) 1.11
Synthesis and characterization of six-arm star poly(delta-valerolactone)-block-methoxy poly(ethylene glycol) copolymers. Biomacromolecules (2005) 0.94
Endocytosis of nanomedicines. J Control Release (2010) 3.23
Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release (2008) 2.63
Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev (2002) 2.19
Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem (2004) 1.94
Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J Pharmacol Exp Ther (2003) 1.61
Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs. J Control Release (2005) 1.52
Polymer micelle with cross-linked ionic core. J Am Chem Soc (2005) 1.40
A macrophage-nanozyme delivery system for Parkinson's disease. Bioconjug Chem (2007) 1.38
Cell-mediated drug delivery. Expert Opin Drug Deliv (2011) 1.33
Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport. Bioconjug Chem (2008) 1.33
Amphiphilic block copolymers enhance cellular uptake and nuclear entry of polyplex-delivered DNA. Bioconjug Chem (2008) 1.31
Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages. J Control Release (2010) 1.28
Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs. J Control Release (2006) 1.28
Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. Bioconjug Chem (2005) 1.26
Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer. Bioconjug Chem (2002) 1.25
Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections. Nanomedicine (2013) 1.21
Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials (2011) 1.21
The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells. Biomaterials (2008) 1.19
The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. Biomaterials (2009) 1.17
Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharm Res (2003) 1.17
Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. J Control Release (2005) 1.16
Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs. Biomaterials (2010) 1.16
Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomedicine (Lond) (2010) 1.12
Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin. J Control Release (2009) 1.11
Synthesis and evaluation of a star amphiphilic block copolymer from poly(epsilon-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier. Bioconjug Chem (2005) 1.11
Nanocarriers for delivery of platinum anticancer drugs. Adv Drug Deliv Rev (2013) 1.11
Comparative manufacture and cell-based delivery of antiretroviral nanoformulations. Int J Nanomedicine (2011) 1.11
Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. J Control Release (2009) 1.11
Polymeric micelles with ionic cores containing biodegradable cross-links for delivery of chemotherapeutic agents. Biomacromolecules (2010) 1.09
Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J Control Release (2004) 1.09
Poly(2-oxazoline)s as polymer therapeutics. Macromol Rapid Commun (2012) 1.07
Effect of pluronic P85 on ATPase activity of drug efflux transporters. Pharm Res (2004) 1.07
Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol (2008) 1.07
Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. Mol Pharm (2006) 1.05
The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase. Biomaterials (2010) 1.04
Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline) micelles. Mol Pharm (2012) 1.03
Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release (2010) 1.03
Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles. J Control Release (2011) 1.03
Mixed polymer micelles of amphiphilic and cationic copolymers for delivery of antisense oligonucleotides. J Drug Target (2004) 1.02
Transport across the blood-brain barrier of pluronic leptin. J Pharmacol Exp Ther (2010) 1.01
Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons. Free Radic Biol Med (2010) 1.01
Block ionomer complexes as prospective nanocontainers for drug delivery. J Control Release (2006) 1.01
Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles. Nanomedicine (Lond) (2011) 0.99
Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery. Bioconjug Chem (2008) 0.99
Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloroplatinum(II). J Control Release (2011) 0.98
Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis. J Cereb Blood Flow Metab (2006) 0.97
Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases. PLoS One (2013) 0.97
Cross-linked antioxidant nanozymes for improved delivery to CNS. Nanomedicine (2011) 0.96
T cell independent mechanism for copolymer-1-induced neuroprotection. Eur J Immunol (2007) 0.96
Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells. Nanomedicine (Lond) (2011) 0.94
Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J Control Release (2004) 0.94
Template-assisted synthesis of nanogels from Pluronic-modified poly(acrylic acid). J Drug Target (2006) 0.93
Protein modification with amphiphilic block copoly(2-oxazoline)s as a new platform for enhanced cellular delivery. Mol Pharm (2010) 0.93
Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant. J Control Release (2008) 0.92
A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer. J Control Release (2013) 0.92
Pluronics and MDR reversal: an update. Mol Pharm (2014) 0.91
Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice. Int J Nanomedicine (2012) 0.91
The utilization of pathogen-like cellular trafficking by single chain block copolymer. Biomaterials (2009) 0.91
Block Ionomer Complex Micelles with Cross-Linked Cores for Drug Delivery. Polym Sci Ser A Chem Phys (2009) 0.90
Synthesis of vesicles on polymer template. J Am Chem Soc (2002) 0.90
Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease. J Nanomed Nanotechnol (2011) 0.89
Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. J Control Release (2013) 0.89
Photocontrolled self-assembly and disassembly of block ionomer complex vesicles: a facile approach toward supramolecular polymer nanocontainers. Langmuir (2010) 0.88
Nanomaterials from ionic block copolymers and single-, double-, and triple-tail surfactants. Langmuir (2007) 0.88
Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury. J Control Release (2012) 0.88
Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery. Nanomedicine (Lond) (2012) 0.88
Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation. Biomaterials (2011) 0.88
The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cells. Biomaterials (2009) 0.87
Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo. Mol Pharm (2012) 0.87
Can nanomedicines kill cancer stem cells? Adv Drug Deliv Rev (2013) 0.86
Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi. J Proteome Res (2006) 0.85
Novel amperometric immunosensors based on iridium oxide matrices. Biosens Bioelectron (2004) 0.85
Chemical engineering of nanogel drug carriers: increased bioavailability and decreased cytotoxicity. Polymer Prepr (2006) 0.85
Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. Nanomedicine (Lond) (2013) 0.85
Block ionomer complexes of PEG-block-poly(4-vinylbenzylphosphonate) and cationic surfactants as highly stable, pH responsive drug delivery system. J Control Release (2012) 0.84